The SUMMIT trial compared the safety and efficacy of tirzepatide among patients with heart failure with preserved ejection fraction (HFpEF) and obesity. Results from the trial concluded that treatment ...
"Wildfires, compound extreme events, climate change and cardiovascular health," are the central theme of an editorial authored by Kai Chen, PhD; Yuan Lu, ScD, and Harlan M. Krumholz, MD, SM, FACC; in ...
A novel artificial intelligence (AI) model applied to a 12-lead electrocardiogram (ECG) image was able to identify individuals at elevated risk of heart failure (HF) across multinational cohorts ...
Overweight and obesity are common in patients with heterozygous familial hypercholesterolemia (HeFH) and are associated with a greater risk of atherosclerotic cardiovascular disease (ASCVD) starting ...
The ACC invites CV Team Section members to volunteer for various opportunities within the College, including writing, speaking, mentoring and more. If interested about opportunities to volunteer, ...
Whether you are a seasoned attendee or attending your first ACC Annual Scientific Session this year, don't miss the CV Team Section Town Hall, taking place ahead of ACC.25 on Wednesday, March 12 at ...
ACC.25 will provide a dynamic and comprehensive learning environment designed to empower the entire cardiovascular care team with cutting-edge science and evidence-based practices. Sessions will ...
ACC's CV Team Section is offering travel awards for cardiovascular team members to attend ACC.25, taking place March 29-31, in Chicago, IL. Expenses including airfare, lodging, meals, and ground ...
Tell us about you so we can serve you better. ACC requests information from its members on gender, ethnicity and race as part of the College's aim to develop a more diverse and inclusive ...
The U.S. Food and Drug Administration (FDA) has approved the FARAPULSE Pulsed Field Ablation System for isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, ...
The U.S. Food and Drug Administration (FDA) has issued a safety communication noting the potential need for early device replacement of Boston Scientific Corporation Accolade pacemaker devices.
Work, practice, expense and liability relative value units (RVUs) are updated annually through the Centers for Medicare and Medicaid Services' Medicare Physician Fee Schedule (PFS) rulemaking. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results